Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 Safety in Actinic Keratosis
NCT00375739Phase 2Completed
- Sponsor
- Peplin
- Start
- Sep 2006
- Primary completion
- Jun 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Sep 2006; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00375739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375739.